Adam Hunt

Adam Hunt

Auto-generated profile, based on publicly available information

Adam Hunt

University of Cambridge

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in Travel Medicine and Infectious Disease
Verified
Journal Article
Open access
SWSandra Willi
Sandra Willi
RLRenata Lüthold
Renata Lüthold
AHAdam Hunt
Adam Hunt
NHNadescha Viviane Hänggi
Nadescha Viviane Hänggi
DSDonikë Sejdiu
Donikë Sejdiu
PSPatricia Schlagenhauf
Patricia Schlagenhauf
There is emerging evidence of long-term sequelae in a considerable proportion of COVID-19 patients after recovery and the spectrum and severity of such sequelae should be systematically reviewed. This review aims to evaluate the available evidence of all intermediate and long-term COVID-19 sequelae affecting formerly healthy adults. A systematic literature search of Embase, WHO, Scopus, Pubmed, Litcovid, bioRxiv and medRxiv was conducted with a cutoff date of the 17th September 2020 according to PRISMA guidelines and registered in PROSPERO (CRD42020208725). Search terms included “COVID-19”, “coronavirus disease 2019”, “SARS-CoV-2”, “sequelae” and “consequence*”. Publications on adult participants, with a confirmed SARS-CoV-2 infection were included. Elderly (>50 years old) and children (<18 years old) were excluded. Bias assessment was performed using a modified Newcastle-Ottawa Scale. A total of 31 papers were included. Study types included prospective and retrospective cohort studies, cross-sectional studies and case reports. Sequelae persistence since infection spanned 14 days to three months. Sequelae included persistent fatigue (39–73% of assessed persons), breathlessness (39–74%), decrease in quality of life (44–69%), impaired pulmonary function, abnormal CT findings including pulmonary fibrosis (39–83%), evidence of peri-/perimyo-/myocarditis (3–26%), changes in microstructural and functional brain integrity with persistent neurological symptoms (55%), increased incidence of psychiatric diagnoses (5.8% versus 2.5–3.4% in controls), incomplete recovery of olfactory and gustatory dysfunction (33–36% of evaluated persons). A variety of organ systems are affected by COVID-19 in the intermediate and longer-term after recovery. Main sequelae include post-infectious fatigue, persistent reduced lung function and carditis. Careful follow-up post COVID 19 is indicated to assess and mitigate possible organ damage and preserve life quality.

24 February 2024 in Neuroscience & Biobehavioral Reviews
Verified
Journal Article
Open access
AHAdam Hunt
Adam Hunt
GMGiuseppe Pierpaolo Merola
Giuseppe Pierpaolo Merola
TCTom Carpenter
Tom Carpenter
AJAdrian V. Jaeggi
Adrian V. Jaeggi
Addiction poses significant social, health, and criminal issues. Its moderate heritability and early-life impact, affecting reproductive success, poses an evolutionary paradox: why are humans predisposed to addictive behaviours? This paper reviews biological and psychological mechanisms of substance and behavioural addictions, exploring evolutionary explanations for the origin and function of relevant systems. Ancestrally, addiction-related systems promoted fitness through reward-seeking, and possibly self-medication. Today, psychoactive substances disrupt these systems, leading individuals to neglect essential life goals for immediate satisfaction. Behavioural addictions (e.g. video games, social media) often emulate ancestrally beneficial behaviours, making them appealing yet often irrelevant to contemporary success. Evolutionary insights have implications for how addiction is criminalised and stigmatised, propose novel avenues for interventions, anticipate new sources of addiction from emerging technologies such as AI. The emerging potential of glucagon-like peptide 1 (GLP-1) agonists targeting obesity suggest the satiation system may be a natural counter to overactivation of the reward system.

31 May 2022 in Evolutionary Human Sciences
Verified
Journal Article
Open access
PDF file
AHAdam D. Hunt
Adam D. Hunt
AJAdrian V. Jaeggi
Adrian V. Jaeggi
Traditional evolutionary theory invoked natural and sexual selection to explain species- and sex-typical traits. However, some heritable inter-individual variability in behaviour and psychology – personality – is probably adaptive. Here we extend this insight to common psychopathological traits. Reviewing key findings from three background areas of importance – theoretical models, non-human personality and evolved human social dynamics – we propose that a combination of social niche specialisation, negative frequency-dependency, balancing selection and adaptive developmental plasticity should explain adaptation for individual differences in psychology – ‘specialised minds’ – explaining some variance in personality and psychopathology trait dimensions, which share various characteristics. We suggest that anthropological research of behavioural differences should be extended past broad demographic factors (age and sex) to include individual specialisations. As a first step towards grounding psychopathology in ancestral social structure, we propose a minimum plausible prevalence, given likely ancestral group sizes, for negatively frequency-dependent phenotypes to be maintained as specialised tails of adaptive distributions – below the calculated prevalence, specialisation is highly unlikely. For instance, chronic highly debilitating forms of autism or schizophrenia are too rare for such explanations, whereas attention-deficit-hyperactivity disorder and broad autism phenotypes are common enough to have existed in most hunter-gatherer bands, making adaptive explanations more plausible.

17 January 2024 in Autism Research
Verified
Journal Article
Open access
AHAdam D. Hunt
Adam D. Hunt
TPTanya L. Procyshyn
Tanya L. Procyshyn
Perspectives on autism and psychiatric conditions are affected by a mix of scientific and social influences. Evolutionary psychiatry (EP) and the neurodiversity movement are emerging paradigms that reflect these distinct influences, with the former grounded in scientific theory and the latter driven by political and social principles. Despite their separate foundations, there is a significant overlap between EP and neurodiversity that has not been explored. Specifically, both paradigms reframe disorders as natural cognitive differences rather than disease; expand the concept of “normal” beyond that implied in modern psychiatry; focus on relative strengths; recognize that modern environments disadvantage certain individuals to cause functional impairment; emphasize cognitive variation being socially accommodated and integrated rather than treated or cured; and can help reduce stigmatization. However, in other ways, they are distinct and sometimes in conflict. EP emphasizes scientific explanation, defines “dysfunction” in objective terms, and differentiates heterogenous cases based on underlying causes (e.g. autism due to de novo genetic mutations). The neurodiversity movement emphasizes social action, removes barriers to inclusion, promotes inclusive language, and allows unrestricted identification as neurodivergent. By comparing and contrasting these two approaches, we find that EP can, to some extent, support the goals of neurodiversity. In particular, EP perspectives could be convincing to groups more responsive to scientific evidence and help achieve a middle ground between neurodiversity advocates and critics of the movement.

22 November 2022 in Evolution, Medicine, and Public Health
Verified
Journal Article
Open access
PDF file
AHAdam D Hunt
Adam D Hunt
PSPaul St-John Smith
Paul St-John Smith
RARiadh Abed
Riadh Abed
The biopsychosocial model remains the de facto framework of current healthcare, but lacks causational depth, scientific rigour, or any recognition of the importance of evolutionary theory for understanding health and disease. In this article it is updated to integrate Tinbergen’s four questions with the three biopsychosocial levels. This ‘evobiopsychosocial’ schema provides a more complete framework for understanding causation of medical conditions. Its application is exemplified by tabulating depression, rheumatoid arthritis and COVID-19 within its format, which highlights the direct research and practical applications uniquely offered by evolutionary medicine. An evobiopsychosocial framework can serve as a useful tool to introduce evolutionary concepts into mainstream medicine by highlighting the broad and specific contributions of evolutionary analysis to researching, treating and preventing health conditions, providing a suitable next step for the mainstream model of medicine.

11 March 2025 in Biological Reviews
Verified
Journal Article
Open access
AHAdam D. Hunt
Adam D. Hunt
AJAdrian V. Jaeggi
Adrian V. Jaeggi
Evolutionary explanations of mental disorders are a longstanding aim of evolutionary psychiatry, but have suffered from complexities including within‐disorder heterogeneity and environmental effects of contemporary societies obscuring possible ancestral functions. Studying the relevant processes of human evolution directly is not possible, so hypotheses have remained speculative, exaggerating “just‐so storytelling” critiques. This is despite significant evidence existing in genetics, neuroscience and epidemiology, all of which bears some inferential relevance to evolutionary hypotheses, but which is often not marshalled in a systematic way. To utilise this evidence best to investigate evolutionary explanations of psychiatric (or other) traits we present a novel framework of evidence synthesis and analysis and exemplify it by systematically reviewing evidence related to autism. In the five stages of this “DCIDE framework” analysis, Description identifies a trait to explain and Categorisation initially excludes verifiably non‐adaptive cases by utilising evidence from genetics, neuroscience, and environmental factors. Integration then hones a target for adaptive explanation by considering evidence of age of onset, environmental effects, duration, prevalence and sex differences, incorporating relevant correlated traits visible to selection. Evolutionary hypotheses are then Depicted and Evaluated for their ability to explain all the evidence at hand, using standardised areas of evidence and theoretically motivated principles (e.g. traits arising at birth and lasting for life have different plausible explanations than traits arising in adolescence and receding in adulthood). Competing evolutionary hypotheses can thus be systematically compared for their sufficiency in explaining a wide range of available evidence. In the DCIDE review of autism, when Described with current diagnostic criteria, up to 20% of cases Categorise as non‐adaptive, primarily caused by de novo mutations and environmental trauma. The remaining cases are eligible for adaptive explanation. For Integrating genetically correlated phenotypes, evidence of high prevalence of subclinical familial traits and camouflaged female cases is necessary. Competing Depictions contrast a high intelligence by‐product hypothesis with social niche specialisation for high “systemising” cognition. In Evaluation, broad evidence supports the social niche hypothesis while the intelligence by‐product hypothesis fails to predict various lines of evidence. This provides not only the most robust synthesis of autism research relevant to evolutionary explanation to date, but is a first example of how the structure of the DCIDE framework can allow improved systematic evolutionary analysis across psychiatric conditions, and may also be adopted to strengthen evolutionary psychology more generally, countering just‐so storytelling and cherry‐picking critiques.